Qtron Investments’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,197
Closed -$59.2K 478
2023
Q3
$59.2K Buy
1,197
+490
+69% +$24.2K 0.01% 400
2023
Q2
$55.3K Buy
+707
New +$55.3K 0.01% 400